- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Lymphatic Vessel.
Displaying page 1 of 1.
EudraCT Number: 2014-002501-38 | Sponsor Protocol Number: LY-OCCL-PRESSURE-1 | Start Date*: 2015-07-08 |
Sponsor Name:ULB - Unité de Recherche en Lymphologie | ||
Full Title: The occlusion pressure of superficial lymphatics in the upper extremity of healthy volunteers: A Near infrared lymphofluoroscopy approach | ||
Medical condition: lymphatic pressure in upper limb from healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004954-58 | Sponsor Protocol Number: 2013-617 | Start Date*: 2014-01-17 | |||||||||||
Sponsor Name:Bispebjerg University Hospital | |||||||||||||
Full Title: Near infrared imaging and measurement of extremity lymphatic collector function using indocyanine green | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004443-20 | Sponsor Protocol Number: HP-LY-CL-2063 | Start Date*: 2018-05-07 | |||||||||||||||||||||
Sponsor Name:Herantis Pharma Plc | |||||||||||||||||||||||
Full Title: A Phase II, double-blind, placebo-controlled, randomized study to assess the efficacy, safety and tolerability of Lymfactin® (AdAptVEGF-C Adenoviral Vector) in combination with a surgical lymph nod... | |||||||||||||||||||||||
Medical condition: Secondary lymphedema associated with the treatment of breast cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001761-11 | Sponsor Protocol Number: 300488 | Start Date*: 2015-08-31 | ||||||||||||||||
Sponsor Name:The Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital | ||||||||||||||||||
Full Title: Lymphatic dysfunction as a cause of calcium channel blocker oedema in post-menopausal women | ||||||||||||||||||
Medical condition: Calcium channel antagonist induced peripheral edema in post-menopausal women. We hypothesize that this condition is partly due to impaired lymphatic function in these patients. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000648-16 | Sponsor Protocol Number: BAY59-7939/19365 | Start Date*: 2017-06-21 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Single-dose, open-label, randomized, 2-way crossover bioequivalence study of 10 mg granules for oral suspension rivaroxaban versus 10 mg tablets rivaroxaban under fasted condition in healthy subjects | |||||||||||||
Medical condition: Prevention and treatment of thromboembolic disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000609-18 | Sponsor Protocol Number: BAY59-7939/19366 | Start Date*: 2017-06-20 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Single-dose, open-label, randomized, 2-way crossover bioequivalence study of 20 mg granules for oral suspension rivaroxaban versus 20 mg tablets rivaroxaban under fed condition in healthy subjects | |||||||||||||
Medical condition: Prevention and treatment of thromboembolic disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004575-13 | Sponsor Protocol Number: TRAPS-1.5 | Start Date*: 2014-10-29 |
Sponsor Name:Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova | ||
Full Title: A prospective, randomized clinical trial comparing Rivaroxaban vs warfarin in high risk patients with antiphospholipid syndrome (TRAPS). | ||
Medical condition: THROMBOEMBOLISM PREVENTION | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000967-10 | Sponsor Protocol Number: RC31/14/7441 | Start Date*: 2019-05-24 |
Sponsor Name:University Hospital Toulouse | ||
Full Title: Autologous transplantation of Adipose tissue derived mesenchymal Stroma/stem Cells (ASC) in patients with critical limb ischemia: a phase II study (ACellDream 2). | ||
Medical condition: Patients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CL... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003075-11 | Sponsor Protocol Number: 9HB01EXT | Start Date*: 2011-12-05 | |||||||||||
Sponsor Name:Biogen Idec Research Ltd | |||||||||||||
Full Title: An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant, Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes i... | |||||||||||||
Medical condition: The medical condition to be investigated is Hemophilia B, or Christmas disease. Hemophilia B is a deficiency in the clotting FIX and is a recessively inherited coagulation disorder due to an X-chro... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) SE (Completed) PL (Completed) IT (Completed) IE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003629-27 | Sponsor Protocol Number: 998HB303 | Start Date*: 2014-05-20 | |||||||||||
Sponsor Name:Bioverativ Therapeutics Inc. | |||||||||||||
Full Title: An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein (rFIXFc; BIIB029) in the Prevention and Treatment of Bleeding in Previously U... | |||||||||||||
Medical condition: Hemophilia B (congenital coagulation factor IX [FIX] deficiency; Christmas disease) is an X-linked bleeding disorder that occurs predominantly in males, characterized by a deficiency of functional ... | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) DE (Completed) SE (Completed) BE (Completed) ES (Completed) IT (Completed) DK (Completed) NL (Completed) PL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005512-10 | Sponsor Protocol Number: 997HA306 | Start Date*: 2014-07-30 | ||||||||||||||||
Sponsor Name:Bioverativ Therapeutics Inc. | ||||||||||||||||||
Full Title: An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc; BIIB031) in the Prevention and Treatment of Bleeding in Previous... | ||||||||||||||||||
Medical condition: Hemophilia A | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) IE (Prematurely Ended) IT (Completed) ES (Prematurely Ended) SE (Prematurely Ended) DE (Prematurely Ended) PL (Prematurely Ended) FR (Completed) DK (Completed) NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003076-36 | Sponsor Protocol Number: 9HB02PED | Start Date*: 2012-05-29 | |||||||||||
Sponsor Name:Biogen Idec Research Ltd | |||||||||||||
Full Title: Open-label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in the Prevention and Treatment of Bleeding Episodes in... | |||||||||||||
Medical condition: The medical condition to be investigated is Hemophilia B, or Christmas disease. Hemophilia B is a deficiency in the clotting FIX and is a recessively inherited coagulation disorder due to an X-chro... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) IE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014295-21 | Sponsor Protocol Number: 998HB102 | Start Date*: 2010-05-06 | |||||||||||
Sponsor Name:Biogen Idec Hemophilia Inc. | |||||||||||||
Full Title: B-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant, Long-acting Coagulation Factor IX Fc fusion protein (rFIXFc) in the Prevention and Treat... | |||||||||||||
Medical condition: The medical condition to be investigated is Hemophilia B, or Christmas disease. Hemophilia B is a deficiency in the clotting FIX and is a recessively inherited coagulation disorder due to an X-chro... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DE (Completed) FR (Completed) PL (Completed) BE (Completed) IT (Completed) NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003320-16 | Sponsor Protocol Number: CEL-03 | Start Date*: 2020-12-23 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:CeleCor Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study to assess the safety and efficacy of a single subcutaneous injection of zalunfiban in subjects with S... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Subjects with documented STEMI, presenting with persistent ischemic chest pain (>10 minutes) and new ≥2 mm ST-segment elevation in 2 adjacent ECG leads, in whom the total duration of symptoms to di... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) CZ (Trial now transitioned) HU (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.